To curb unnecessary and prolonged prescribing of antidepressants, we need to support general practitioners to initiate antidepressants less often and to review and stop antidepressants more often.

Australia’s new national health priority of Quality Use of Medicine and Medicine Safety should stimulate all stakeholders including consumers to work together to address off-label medicine use.

A series of Commonwealth and state initiatives have been enacted to ensure ongoing access to medications during the COVID-19 pandemic.

GPs receive updates to their knowledge on a daily basis. They want accurate summaries of a medicine’s properties, efficacy and side-effect profile from trusted sources on which to base a decision.

Buprenorphine–naloxone is well tolerated by patients with chronic pain, and has the potential to improve pain scores and affective symptoms.